Medical News

RSS

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.

15 Mar 2010

CPF, PFF applaud PF patients' efforts to plead with FDA Advisory Panel regarding lack of treatment options

The Coalition for Pulmonary Fibrosis and the Pulmonary Fibrosis Foundation are applauding the efforts of Pulmonary Fibrosis (PF) patients and family members for their work to convey to the FDA and an FDA Advisory Committee the sense of urgency and desperation regarding the disease and the lack of treatment options.

15 Mar 2010

American Oriental Bioengineering's fiscal 2009 revenues up 11.9%

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the fourth quarter and fiscal year ended December 31, 2009.

15 Mar 2010

Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy

Every year more than 100,000 women in the United States undergo a lumpectomy, a conservative procedure to remove cancerous tumors while preserving the breast. The surgeon's goal is to attain a tumor-free, or negative, surgical margin the first time they operate. Current surgical tools may cause heat damage to the tissue samples needed for examination by a pathologist in order to identify the presence of cancerous cells on the edges of tumors.

15 Mar 2010

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

The presence of plaque on an abdominal CT scan is a strong predictor of coronary artery disease and mortality, according to a Henry Ford Hospital study.

15 Mar 2010

Orexo AB summons shareholders for extraordinary general meeting

The shareholders in Orexo AB (publ) are summoned to an extraordinary general meeting to be held on Wednesday 31 March 2010, at 10.00 am at IVA’s Konferenscenter, Grev Turegatan 16, in Stockholm, Sweden.

15 Mar 2010

Impact of tumor surgery on sexual function

Sexual problems are frequent after operations for carcinoma of the rectum. Christian Schmidt et al. describe the consequences for quality of life in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107[8]: 123-30).

15 Mar 2010

Scientists develop nitric oxide-releasing cloth to make therapeutic socks for diabetes patients

Scientists in Texas are reporting development of a first-of-its-kind cloth that releases nitric oxide gas - an advance toward making therapeutic socks for people with diabetes and a wrap to help preserve organs harvested for transplantation. The study is in ACS' Chemistry of Materials, a bi-weekly journal.

15 Mar 2010

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.

15 Mar 2010

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

NDS Surgical Imaging today announced the launch of ZeroWire®, a medical-grade wireless Full HD video solution for minimally-invasive surgery, GI and interventional suites. Customers in the European Union will be offered this high-technology video solution which is customized to meet the video transmission challenges of the operating room. NDSsi has plans to also launch its ZeroWire solution in the United States and Asia-Pacific regions in the coming months.

15 Mar 2010

Matrix signs MOU with PharmaVentures

Matrix Corporate Capital and PharmaVentures Limited today announced the signing of a Memorandum of Understanding ("MOU") covering strategic transactions in the biotech, pharmaceutical and med tech sectors. The companies will work together to identify licensing, buyout, investment, IPO and consolidation opportunities which bring together both strategic expertise and capital from Europe's dedicated healthcare investors.

15 Mar 2010

Rhythm Pharmaceuticals completes $21M Series A equity financing

Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed the first close on its Series A equity financing of $21 million. The financing was led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Ipsen.

15 Mar 2010

First Edition: March 15, 2010

Today's headlines drive home one key point -- for the Democrats' health bill, it's all about gathering the votes.

15 Mar 2010

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have discovered that "microtentacles," or extensions of the plasma membrane of breast cancer cells, appear to play a key role in how cancers spread to distant locations in the body. Targeting these microtentacles might prove to be a new way to prevent or slow the growth of these secondary cancers, the scientists say.

15 Mar 2010

NDA for BYDUREON: FDA issues complete response letter

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).

15 Mar 2010

Toshiba America Medical Systems to showcase Infinix VF-i biplane system at ACC 2010

When working on patients in a hybrid setting, it is critical the imaging system provides outstanding image quality, as well as the flexibility to reach ancillary equipment and the patient quickly and easily. Designed to create a best-in-class hybrid suite, Toshiba America Medical Systems, Inc. will showcase its InfinixTM VF-i biplane system with two identical 12'' x 12'' flat panel detectors and the CAT 880B hybrid catheterization table at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14 - 16, 2010 (Booth # 1944).

15 Mar 2010

HealthInsight provides HealthMedia online Digital Coaching solution to Sutter Physician Services

HealthInsight, provider of the leading value-based health care administration platform, today announced the company is providing the HealthMedia®online Digital Coaching solution to Sutter Physician Services for their new Wellness 2010 program. The combination of HealthInsight’s value-based compliance tracking and HealthMedia’s online Digital Coaching solution will help Sutter dramatically reduce their health care costs while improving their employees’ health.

15 Mar 2010

Christiana Care Breast Center nurse awarded 2010 Pearl Moore Making a Difference Award from ONS

Darcy Burbage, RN, MSN, AOCN®, CBCN®, clinical nurse specialist at the Christiana Care Breast Center at the Helen F. Graham Cancer Center, is the 2010 recipient of the Pearl Moore Making a Difference Award from the Oncology Nursing Society.

15 Mar 2010

FGX International becomes wholly-owned subsidiary of Essilor

FGX International Holdings Limited announced that it has completed its merger with a subsidiary of Essilor International of Charenton-le-Pont, France.

15 Mar 2010

More focus on reaching MDGs needed, development officials say

During a conference in London Thursday, development officials urged world leaders to "accelerate efforts to meet the Millennium Development Goals (MDGs) by 2015 and [said] rich countries must make good on promises to boost aid to poorer nations," Reuters AlertNet reports.

15 Mar 2010

Medical News

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

CPF, PFF applaud PF patients' efforts to plead with FDA Advisory Panel regarding lack of treatment options

American Oriental Bioengineering's fiscal 2009 revenues up 11.9%

Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

Orexo AB summons shareholders for extraordinary general meeting

Impact of tumor surgery on sexual function

Scientists develop nitric oxide-releasing cloth to make therapeutic socks for diabetes patients

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

Matrix signs MOU with PharmaVentures

Rhythm Pharmaceuticals completes $21M Series A equity financing

First Edition: March 15, 2010

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

NDA for BYDUREON: FDA issues complete response letter

Toshiba America Medical Systems to showcase Infinix VF-i biplane system at ACC 2010

HealthInsight provides HealthMedia online Digital Coaching solution to Sutter Physician Services

Christiana Care Breast Center nurse awarded 2010 Pearl Moore Making a Difference Award from ONS

FGX International becomes wholly-owned subsidiary of Essilor

More focus on reaching MDGs needed, development officials say

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News